DOI:
10.1055/s-00000133
Gastroenterologie up2date
LinksClose Window
References
Lorenzen S, Duyster J, Lersch C. et al.
Capecitabine plus docetaxel every three weeks in first- and second-line metastatic oesophageal cancer: final results of a phase II trial.
Brit J Cancer 2005; 92: 2129-2133
We do not assume any responsibility for the contents of the web pages of other providers.